ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,357.73
0.04%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,309.135
0.04%
Brent Oil
83.825
0.32%
Bitcoin
61,069.07
-0.19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) News

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:POLB
DateTimeSourceHeadlineSymbolCompany
09/05/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Annual Report & AGM NoticeLSE:POLBPoolbeg Pharma Plc
01/05/202416:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202416:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Significant POLB 001 Patent Granted in USALSE:POLBPoolbeg Pharma Plc
30/04/202416:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202416:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202407:02RNS Regulatory NewsPoolbeg Pharma PLC Appointment of Joint BrokerLSE:POLBPoolbeg Pharma Plc
30/04/202407:01RNS Regulatory NewsPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug CandidateLSE:POLBPoolbeg Pharma Plc
30/04/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Results for the year ended 31 December 2023LSE:POLBPoolbeg Pharma Plc
29/04/202407:00RNS Regulatory NewsPoolbeg Pharma PLC TR-1: Notification of major holdingsLSE:POLBPoolbeg Pharma Plc
20/03/202416:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202416:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202407:00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 US Patent UpdateLSE:POLBPoolbeg Pharma Plc
22/02/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Director/PDMR ShareholdingLSE:POLBPoolbeg Pharma Plc
19/02/202413:42RNS Regulatory NewsPoolbeg Pharma PLC Director Share PurchaseLSE:POLBPoolbeg Pharma Plc
15/02/202416:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202416:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Board Role Change and Launch of EIPLSE:POLBPoolbeg Pharma Plc
12/02/202419:44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202419:44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Market Opportunity for POLB 001 for CRSLSE:POLBPoolbeg Pharma Plc
17/01/202413:58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202413:58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202407:00UK RegulatoryPoolbeg Pharma PLC Further data shows POLB001 potential in cancer CRSLSE:POLBPoolbeg Pharma Plc
20/12/202320:00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202320:00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202307:00UK RegulatoryPoolbeg Pharma PLC RSV AI Drug Candidate Analysis UpdateLSE:POLBPoolbeg Pharma Plc
11/12/202307:00UK RegulatoryPoolbeg Pharma PLC POLB 001 Data Presented at ASHLSE:POLBPoolbeg Pharma Plc
30/11/202307:00UK RegulatoryPoolbeg Pharma PLC Directorate ChangeLSE:POLBPoolbeg Pharma Plc
21/11/202314:39Alliance NewsAlliance NewsTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo FisherLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Your Recent History

LSE
POS
Plexus
LSE
TERN
Tern
LSE
ITV
Itv
LSE
BIRD
Blackbird
LSE
GWMO
Great Western Mining
LSE
GOLD
LSE
SYME
Supply@me Capital
LSE
SCE
Surface Transforms
LSE
KEFI
Kefi Gold And Copper
LSE
FDEV
Frontier Developments
LSE
TYM
Tertiary Minerals
LSE
PET
Petrel Resources
LSE
DEC
Diversified Energy
LSE
LND
Landore Resources
LSE
VAST
Vast Resources
LSE
BOO
Boohoo
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved